This review summarizes the basic mechanisms of action of digitalis and discusses its role in contemporary clinical practice.
Answers are grounded in this paper and cite their sources.
May guide digitalis use in select HF cases; leaves open efficacy questions in contemporary regimens.
ALTHOUGH digitalis has been in clinical use for more than 200 years, not until the late 1920s was it clearly demonstrated that digitalis has a positive inotropic effect on the heart, enhancing the contractile state of the intact ventricle.1 Nearly 60 more years passed before a consensus emerged about the underlying cellular mechanism whereby cardiac glycosides augment the force of contraction of the normal and failing heart. In this brief review, I shall summarize our current understanding of the basic mechanisms of the action of digitalis and offer a view of the appropriate place of cardiac glycosides in the contemporary . . .
No takes yet. Share an insight, caveat, or question.
A 1988 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: